Total Debt
$5.6M
Net Debt
-$274.1M
Amylyx Pharmaceuticals, Inc. currently has $5.6M in total debt. Net debt is -$274.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
AMLX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.01 | 0.28 | -0.27Net Cash | 0.29 | 1.9% |
| 2025-12-31 | 0.01 | 0.32 | -0.31Net Cash | 0.33 | 1.8% |
| 2025-09-30 | 0.01 | 0.34 | -0.34Net Cash | 0.36 | 1.6% |
| 2025-06-30 | 0.01 | 0.18 | -0.17Net Cash | 0.19 | 3.1% |
| 2025-03-31 | 0.00 | 0.20 | -0.20Net Cash | 0.22 | 0.6% |
| 2024-12-31 | 0.00 | 0.18 | -0.17Net Cash | 0.19 | 1.0% |
| 2024-09-30 | 0.00 | 0.23 | -0.23Net Cash | 0.25 | 1.0% |
| 2024-06-30 | 0.00 | 0.31 | -0.31Net Cash | 0.33 | 0.9% |
| 2024-03-31 | 0.00 | 0.37 | -0.37Net Cash | 0.42 | 0.9% |
| 2023-12-31 | 0.00 | 0.37 | -0.37Net Cash | 0.52 | 0.8% |
| 2023-09-30 | 0.00 | 0.36 | -0.35Net Cash | 0.47 | 1.0% |
| 2023-06-30 | 0.01 | 0.36 | -0.35Net Cash | 0.45 | 1.2% |
| 2023-03-31 | 0.01 | 0.35 | -0.34Net Cash | 0.41 | 1.4% |
| 2022-12-31 | 0.01 | 0.35 | -0.34Net Cash | 0.39 | 1.6% |
| 2022-09-30 | 0.01 | 0.16 | -0.16Net Cash | 0.18 | 3.7% |
| 2022-06-30 | 0.01 | 0.21 | -0.20Net Cash | 0.23 | 3.1% |
| 2022-03-31 | 0.01 | 0.26 | -0.25Net Cash | 0.27 | 2.6% |
| 2021-12-31 | 0.00 | 0.10 | -0.10Net Cash | 0.11 | 0.0% |
| 2021-09-30 | 0.00 | 0.13 | -0.13Net Cash | 0.13 | 0.2% |